Perampanel in Patients with a History of Psychiatric Illness: Post Hoc Analysis of Four Randomised Phase III Studies and their Open-Label Extensions

被引：0
|
作者：
Malhotra, Manoj [1 ]
Patten, Anna [2 ]
Kanner, Andres [3 ]
机构：
[1] Eisai Inc, Woodcliff Lake, NJ USA
[2] Eisai Europe Ltd, Hatfield, Herts, England
[3] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
来源：
EPILEPSIA | 2021年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
253
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [21] Predictors of Sustainability of Response With Cenobamate: Post-hoc Subset Analysis of a Phase 3, Open-Label, Study
    Stern, Sean
    Wechsler, Robert
    Kerr, Wesley T.
    Wade, Clarence T.
    Vossler, David G.
    Rosenfeld, William E.
    NEUROLOGY, 2023, 100 (17)
  • [22] Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open-label study
    Sperling, Michael R.
    Abou-Khalil, Bassel
    Aboumatar, Sami
    Bhatia, Perminder
    Biton, Victor
    Klein, Pavel
    Krauss, Gregory L.
    Vossler, David G.
    Wechsler, Robert
    Ferrari, Louis
    Grall, Mindy
    Rosenfeld, William E.
    EPILEPSIA, 2021, 62 (12) : 3005 - 3015
  • [23] Efficacy and Tolerability of Solifenacin in Patients Aged ≥ 65 Years with Overactive Bladder: Post-Hoc Analysis of 2 Open-Label Studies
    Capo', James P.
    Lucente, Vincent
    Forero-Schwanhaeuser, Sergio
    He, Weizhong
    POSTGRADUATE MEDICINE, 2011, 123 (01) : 94 - 104
  • [24] Efficacy and Safety of Adjunctive Perampanel in South Korean Patients with Partial-Onset Seizures (POS) or Primary Generalized Tonic-Clonic Seizures (PGTCS): Post Hoc Analysis of Phase II and III Double-Blind and Open-Label Extension (OLEx) Studies
    Malhotra, Manoj
    Ngo, Leock Y.
    Patten, Anna
    Salah, Alejandro
    NEUROLOGY, 2020, 94 (15)
  • [25] Assessment of the long-term efficacy and safety of adjunctive perampanel: pooled analyses of four open-label extension studies
    Rektor, Ivan
    Krauss, Gregory L.
    Inoue, Yushi
    Kaneko, Sunao
    Williams, Betsy
    Patten, Anna
    Bibbiani, Francesco
    Laurenza, Antonio
    Wechsler, Robert T.
    NEUROLOGY, 2017, 88
  • [26] Lipid profile with eslicarbazepine acetate and carbamazepine monotherapy in adult patients with newly diagnosed focal seizures: post hoc analysis of a phase III trial and open-label extension study
    Trinka, Eugen
    Rocamora, Rodrigo
    Chaves, Joao
    Koepp, Mathias J.
    Rueegg, Stephan
    Holtkamp, Martin
    Moreira, Joana
    Fonseca, Miguel M.
    Castilla-Fernandez, Guillermo
    Ikedo, Fabio
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2023, 16
  • [27] Sustainability of seizure reduction and seizure control with adjunctive cenobamate: Post hoc analysis of a phase 3, open-label study
    Vossler, David G. G.
    Rosenfeld, William E. E.
    Stern, Sean
    Wade, Clarence T. T.
    Ferrari, Louis
    Kerr, Wesley T. T.
    Wechsler, Robert
    EPILEPSIA, 2023, 64 (10) : 2644 - 2652
  • [28] Efficacy of Cenobamate for Uncontrolled Focal Seizures: Post-hoc Analysis of a Phase 3, Multicenter, Open-Label Study
    Sperling, Michael R.
    Abou-Khalil, Bassel
    Aboumatar, Sami
    Bhatia, Perminder
    Biton, Victor
    Klein, Pavel
    Krauss, Gregory L.
    Vossler, David G.
    Wechsler, Robert
    Ferrari, Louis
    Kamin, Marc
    Grall, Mindy
    Rosenfeld, William E.
    NEUROLOGY, 2021, 96 (15)
  • [29] Assessment of the long-term efficacy and safety of adjunctive perampanel in tonic-clonic seizures: Analysis of four open-label extension studies
    Rektor, Ivan
    Krauss, Gregory L.
    Inoue, Yushi
    Kaneko, Sunao
    Williams, Betsy
    Patten, Anna
    Malhotra, Manoj
    Laurenza, Antonio
    Wechsler, Robert T.
    EPILEPSIA, 2020, 61 (07) : 1491 - 1502
  • [30] Efficacy of cenobamate by focal seizure subtypes: Post-hoc analysis of a phase 3, multicenter, open-label study
    Rosenfeld, William E.
    Ferrari, Louis
    Kamin, Marc
    EPILEPSY RESEARCH, 2022, 183
12345